Navigation Links
Boston Scientific, Subsidiaries to Pay $30M to Settle Lawsuit Filed Under False Claims Act; Parker Waichman LLP Applauds Efforts of Whistleblower Who Gets $2.25M
Date:11/14/2013

New York, New York (PRWEB) November 14, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of individuals against fraud, commends private citizen/whistleblower James Allen, who filed a qui tam lawsuit against Boston Scientific Corp. and subsidiaries Guidant LLC, Guidant Sales LLC and Cardiac Pacemakers Inc. (United States ex rel Allen v Guidant LLC et al, Case No. 0:11-cv-00022-DWF-AJB, U.S. District Court, District of Minnesota; the lawsuit was filed on March 14, 2012). The companies have since agreed to pay $30 million to settle allegations that, between 2002 and 2005, they knowingly sold defective heart devices that were implanted into Medicare patients, according to an Oct. 17 press release from the U.S. Justice Department, which further noted that Mr. Allen gets $2.25 million as provided under the False Claims Act.

The lawsuit was filed by Mr. Allen after he was implanted with one of the defective devices, according to court documents, which noted that the Prizm 2 and the Renewal 1 and 2 were the devices alleged to be defective. The devices were designed to detect if a patient’s heart fell into an irregular rhythm, which would signify risk of cardiac arrest, according to court documents, which added that the devices were designed to then correct the heartbeat by issuing an electrical pulse to shock it back to a normal rhythm. The alleged defect, however, was that the devices were susceptible to “arcing,” said the court documents. Arcing occurs when the device detects the irregular heartbeat and delivers the shock, only instead of the current traveling to the heart, the current “arcs” back to the device itself, said the court documents, which added that this causes the device to short circuit, rendering the device ineffective.

A Boston Scientific spokesman report
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Journal of Traumatic Stress Study Analyzes Psychological Effects of Marathon Bombing on Boston-Area Veterans with Post-Traumatic Stress Disorder (PTSD)
2. Transvaginal Mesh Lawsuits News: AMS, Boston Scientific Bellwether Trials Planned for Early 2014, Rottenstein Law Group LLP Reports
3. “Intercellular” Gallery Exhibit Opens at Boston Children’s Museum
4. Edwards, Medtronic and Boston Scientific Lead Market Growth for Cardiac Surgery, Cardiac Rhythm Management and Interventional Cardiology Devices, Reports iData Research, Inc.
5. Boston MedFlight Wins American Eurocopter Vision Zero Aviation Safety Award
6. Visage Sculpture, Premiere Cosmetic Clinic of Boston, Reports Shorter-lasting Results of Fillers in Athletes and Offers a Solution
7. Boston Childrens issues $150K for pediatric innovation awards
8. Gorton’s Celebrates National Seafood Month with “Wicked Good Seafood” Campaign; Promotion Includes Sweepstakes, Offers One Grand Prize Trip to Boston
9. Author of Best Selling Book '52 Ways to Beat Depression Naturally' to Come to Boston's Own Harvard Coop Bookstore for Book Signing - Proceeds to Go to One Fund
10. Salespod, Inc., Maker of Agile Field Sales and Retail Execution Solution to Exhibit at MobileMonday Boston’s MIT Museum Showcase
11. 2013 RAPS: The Regulatory Convergence in Boston to Feature Harvard Health School Dean, Biomedical Innovators, FDA and Global Regulatory Officials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 In a nested-case ... of the world with a relatively low incidence of liver ... liver cancer, according to a new study published February ... Institute. , Previous studies have reported this association but ... high liver cancer incidence rate, such as Asia. Katherine A. ...
(Date:2/26/2015)... 2015 marks five years of being recognized ... , Orthodontics is a perfect blend of Dr. ... in biomedical engineering, his artistic talent, his extensive training ... allows Dr. Caggiano to create innovative approaches to solve ... Orthodontic Products’ Best of 2012, a national recognition, for ...
(Date:2/26/2015)... February 26, 2015 Beckman Coulter is ... extracellular vesicles and their cargo in cell-to-cell communication,” which ... their relevance for cell-to-cell communication. The webinar is free ... 2015 at 8:00am PT. , Every cell in the ... (EVs) , often called “exosomes” or “microvesicles.” These vesicles ...
(Date:2/26/2015)... “ KnowNote ” was featured on NewsWatch as part of ... applications on the iOS, Android, and Windows markets. Andrew Tropeano, ... app review and shared with viewers how this application teaches ... , Learning a musical instrument can be difficult. And ... take something they already know and use to learn music ...
(Date:2/26/2015)... Pittsburgh, PA (PRWEB) February 26, 2015 ... Chairman J. Robert Baum, Ph.D. is stepping down as ... succeeded by Joseph C. Guyaux, senior vice chairman of ... chief executive officer, PNC Mortgage. Additionally, Highmark Health President ... the chairman of the board of directors of Highmark ...
Breaking Medicine News(10 mins):Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:A Modern Way to Learn Music was Featured on NewsWatch Television on January 30, 2015 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 3Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 4
... 13 The second annual HealthSaver Caffeinated ... emerging health care discount service, found that the ... followed by Seattle, Chicago, New York and Los ... , The least caffeinated cities are Riverside/San ...
... COLUMBIA, Canada, Jan. 13 InNexus Biotechnology ... http://www.ixsbio.com ), a drug development company commercializing the next ... Linking (DXL(TM)) technology, announces the completion of a large ... lead candidate DXL625 (CD20). The Company also announced ...
... from CoSentry, a leading provider of data center ... of the nation,s premier healthcare providers, announced formation ... an enterprise class data center in Papillion, Neb.The ... requirements of Alegent Health,s hospital and clinical applications ...
... Misuse may cause respiratory distress, researchers say; company says ... -- The popular cold remedy Vicks VapoRub may cause ... toddlers, a new study says. , Doctors at Wake ... girl who had developed severe respiratory distress after the ...
... knee ligament reconstruction markets to grow at rates above ... to Millennium Research GroupWALTHAM, Mass., Jan. 13 ... US Markets for Orthopedic Soft Tissue ... for the use of composite materials in both shoulder ...
... Physical ActivitySACRAMENTO, Calif., Jan. 13 New research suggests ... a few clicks away with Dairy Council of California,s ... chronic diseases like type 2 diabetes, heart disease and ... (47.7 percent) engage in at least 30 minutes of ...
Cached Medicine News:Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 2Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 3Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 4Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 5Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 6Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 7Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 8Health News:InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA 2Health News:CoSentry and Alegent Health Announce Collaboration for Construction of an Enterprise-Class Data Center 2Health News:CoSentry and Alegent Health Announce Collaboration for Construction of an Enterprise-Class Data Center 3Health News:CoSentry and Alegent Health Announce Collaboration for Construction of an Enterprise-Class Data Center 4Health News:Vicks VapoRub Linked to Infant Breathing Problems 2Health News:Vicks VapoRub Linked to Infant Breathing Problems 3Health News:Growing Preference for Composite Materials in Shoulder Fixation and Knee Ligament Reconstruction Markets 2Health News:MyFitness Planner Really Moves You 2
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
(Date:2/26/2015)... 26, 2015 Columbia Laboratories, Inc. (Nasdaq: ... a specialty pharmaceutical company focused on the development ... a Phase II clinical trial for COL-1077, a ... pipelle-directed endometrial biopsy in the second quarter of ... submission feedback from the United States Food and ...
(Date:2/26/2015)... SALT LAKE CITY , Feb. 26, 2015 /PRNewswire/ ... it has launched a "best efforts" follow-on offering of ... unit consists of one share of Series E preferred ... Series E preferred stock will be convertible into four ... will be exercisable into one share of common stock ...
Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
... , , ... Designation , SILVER SPRING, Md., Dec. 23 As ... and accessible, the FDA has scheduled a series of workshops about ... the process. The FDA can grant a special status, known as ...
... , ATLANTA, Dec. 23 MiMedx Group, Inc. ... launched its first product, Paradis Vaso Shield(TM). In April ... for use as a cover for vessels following anterior vertebral ... hydrogel product protected by multiple patents and patent applications, as ...
Cached Medicine Technology:FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 2MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 2MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Medicine Products: